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T his year nearly 1 million people in the United States will de velop non-melanoma skin can cer. T lus is by f.,r the most common neoplasm in Caucasians. The cumulative lifetim e risk is greater than 15%. For many years epidemiologic studies have examined risk 
factors for development of non-m ela nom a skin cancer (reviewe d in 
[1]). Nuplerous environmental and genetic fa ctors have been 
considered . People with occupations involving substantial sun 
exposure such as f., rmers, sailors, or life guards are at increased ri sk. 
Inhabitants of areas with lugh solar radiation such as N ew Mexico 
or Australia have a lugh frequency of skin cancer. The risk of 
non-melanoma skin cancer increases with age . 
Inherited factors have been studied. Fair-skinned people who 
burn easily and tan poorly are at increased risk. People of "Celtic" 
ances try or wi th blue eyes and red or blond hair are more 
susceptible. A few genetic diseases, such as nevoid basal cell 
carcinoma syndrome and xerodenna pigmentosum , have a greatly 
increased risk of non-melanoma skin cancer. 
For most of these risk factors the m echanism of increased cancer 
risk is not unders tood. There is one notable exception : patients 
with xeroderma pigm entosum are known to have defective repa~r 
of DNA damaged by ultraviolet (VV) radiation [2]. The DNA-
repair defect leads to decreased survival of sun-damaged cells and 
an increased frequency of somatic mutations in the surviving cells. 
Thjs higher load ofUV-induced mutations is b~lieved to lead to tile 
more than a thousandfold increased risk of skin cancer in xero~ 
derma pigmentosum patients [3]. Characteristic UV-type mutations 
are found in skin cancers from XP patients . 
R esearchers at J o hns Hopkins University have approached the 
questiop of skin-cancer susceptibility by using an innovative (:om-
bination of molecul ar biology and epidemiology in a series of 
collaborative studies involving the departments of epidemiology, 
biochemistry, and dennatology. They reasoned that if patients with 
xeroderma pig.l11entosum have large defects in DNA repair and a 
huge increase in skin-cancer frequency, then smaller DNA re pair 
de fec ts mig/lt underly the smaller increases in skin-cancer risk 
found in the general population. 
First, they needed a simple, reproducible assay that could de tect 
sm all decreases i.n DNA-repair ability. They settled on a host-cell-
reactivation assay that involved treatment of pure DNA with UV j" 
II j/ 1"O and then introduction of the damaged DNA into human cells. 
The cells processed the d am aged DNA using their own DNA-
repair system, and the repaired DNA w as then an~ 'yzed . Protic-
Sabljic and Kraemer [4] had developed a host-cell-n,activation 
assay utili zing a plasmid containing the gene for chloramphenicol 
acetyl transferase (CAT) as a source of damaged DNA. In tlus 
sensitive assay system the damage produced by a single photoprod-
uct in' the target gene was sufficient to inactivate CAT expression in 
xeroderma pigmentosl1ln cells , whereas expression in normal cells 
was almost unaffected. T hf Hppkins group modifi ed the test for use 
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in human lymphoid cells , simplified the assay of CAT expression , 
and achieved measurem ents with a coeffici ent of variation on the 
order of 5% [5]. They then assembled a group of 88 patients with 
basal cell carcinoma and 135 cancer-free controls with a similar age 
and sex distribution who had mild skin disorqers. The patients and 
controls were carefully examined and questioned about details of 
sun exposure, reactions to sunlight, and family lustory of skin 
cancer. 
The first report of this m olecular epidemiology study of DNA 
repair [6] revealed an age-relilted decline in DNA repair between 
the ages of20 years and 60 years in the control group. In support of 
the hypothesis of a DNA-repair defect in skin-cancer patients, they 
found that younger patients with basal ce\1 carcin om a (in the 
20 -40-year range) had a low DNA-repair rate that was similar to 
that of cop troIs who were in the 51-60-year age range. T he 
differences between the groups, however, were small and w ere not 
observed in m easurem ents of individual patients . 
The paper by Wei et al in tlU! current issue is a m ore detailed 
analysis of tlus data se t. As would be expected from earlier 
epidemiologic studies, the basal cell carcinom a patients were more 
likely to have the following four features than the control group: a) 
skin type I, b) telangiectasia, c) history of frequent sunbatlung, anp 
d) ; 1..-..: or more severe sunbums. T he authors now report tllat the 
basal ce\1 carcinoma patients with these four clinical features had 
significantly lower DNA-repa.ir capacity than controls. T lus sug-
ge~ts the hyp othesis that cumulative UV damage leads to acceler-
ated loss of DNA-repair abili ty , w luch in tum resul ts in an 
increasil1g freq uency of cancer-generating som atic mutations. As in 
tbe earlier analysis , the differences were small and were not 
observed with m easurem ents of individual patients. 
Tlus pioneering work is the fIrst large-sca.l e use of molecular 
techniques that assess cellular function in studies of the epidemiol-
ogy of skin cancer. A similar molecular approach has recently been 
described for familial m elanoma [7]. Studies like tllese should 
provide a means of dissecting the mechanistic link between the 
traditional epidemiologic observations of skin appearance and 
patient behavior and the ultimate generation of skin cancer. 
Ultimately these studies could demonstra te w hy people w ho get 
skin capcer are differ!'!nt. 
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